CLINICAL_TRIALS
trial_result
· 2014-08-22
Clinical Trial Update: Safety of Terbogrel in Patients With Primary Pulmonary Hypertension [Phase 2]
Summary
Phase 2 safety update on terbogrel in patients with pulmonary arterial hypertension; the trial was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Hypertension, Pulmonary | Phase 2 | Status: TERMINATED